Simplex Trading
APYX icon

Simplex Trading’s Apyx Medical APYX Stock Holding History

Simplex Trading’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.3K Sell
7,392
-2,542
-26% -$9.5K ﹤0.01% 6485
2025
Q4 		$34.8K Buy
9,934
+5,347
+117% +$18.6K ﹤0.01% 5983
2025
Q3 		$9K Sell
4,587
-1,082
-19% -$2.29K ﹤0.01% 7935
2025
Q2 		$12K Buy
5,669
+3,094
+120% +$4.36K ﹤0.01% 7151
2025
Q1 		$3K Sell
2,575
-1,192
-32% -$1.64K ﹤0.01% 7772
2024
Q4 		$5K Buy
3,767
+1,943
+107% +$2.72K ﹤0.01% 7567
2024
Q3 		$2K Sell
1,824
-2,740
-60% -$3.46K ﹤0.01% 7942
2024
Q2 		$6K Sell
4,564
-4,156
-48% -$6.13K ﹤0.01% 7729
2024
Q1 		$11K Sell
8,720
-4,643
-35% -$9.88K ﹤0.01% 7518
2023
Q4 		$35K Buy
+13,363
New +$32.4K ﹤0.01% 6411
2023
Q2 		– Sell
-512
Closed -$2.59K – 8899
2023
Q1 		$1K Sell
512
-98
-16% -$286 ﹤0.01% 8632
2022
Q4 		$1K Sell
610
-13,312
-96% -$40.6K ﹤0.01% 8744
2022
Q3 		$62K Sell
13,922
-6,190
-31% -$44.3K ﹤0.01% 6126
2022
Q2 		$117K Buy
+20,112
New +$103K ﹤0.01% 5351
2021
Q2 		– Sell
-18,481
Closed -$178K – 9977
2021
Q1 		$178K Buy
18,481
+16,000
+645% +$160K ﹤0.01% 4922
2020
Q4 		$17K Buy
+2,481
New +$16.4K ﹤0.01% 7067
2020
Q3 		– Sell
-187
Closed -$926 – 7735
2020
Q2 		$1K Buy
187
+110
+143% +$457 ﹤0.01% 7327
2020
Q1 		$0 Buy
+77
New +$517 ﹤0.01% 7541
2019
Q4 		– Sell
-82
Closed – – 7243
2019
Q3 		$0 Sell
82
-1,318
-94% -$9.35K ﹤0.01% 7197
2019
Q2 		$9K Buy
1,400
+1,025
+273% +$5.57K ﹤0.01% 6146
2019
Q1 		$2K Sell
375
-27,271
-99% -$211K ﹤0.01% 6753
2018
Q4 		$179K Buy
27,646
+27,602
+62,732% +$167K ﹤0.01% 3266
2018
Q3 		$0 Buy
+44
New +$245 ﹤0.01% 7351

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Simplex Trading's APYX Position: Q1 2026 in Review

Simplex Trading reduced its Apyx Medical (APYX) stake by 26% in Q1 2026, selling an estimated $9.5K and leaving 7,392 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6485.

Simplex Trading first reported a position in APYX in Q3 2018 and has held it in 23 quarters since. The position peaked at $179K in Q4 2018. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Simplex Trading held 7,392 shares of Apyx Medical worth $27.3K as of Q1 2026.
  • Simplex Trading sold 2,542 Apyx Medical shares in Q1 2026, an estimated $9.5K.
  • Apyx Medical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6485 holding.
  • Simplex Trading first reported a position in Apyx Medical in Q3 2018 and has held it in 23 quarters since.
  • Simplex Trading's Apyx Medical position peaked at $179K in Q4 2018.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.